COMP <GO>
MMED vs HTFL // RETURN ON INVESTED CAPITAL (ROIC)
MiniMed Group Inc. (NASDAQ) VS. Heartflow Inc. (NASDAQ) • 15-METRIC TALLY: MMED 6
— HTFL 5
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MMED
LAST: $18.28 (-5.04%) • MKT CAP: $5.14B
roic
-3.90%
LAST: $59.05 (-2.44%) • MKT CAP: $5.13B
roic
-12.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMED VS. HTFL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMED | HTFL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.20% | 76.80% | -22.60 | HTFL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -3.90% | -12.00% | +8.10 | MMED | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.75% | -1.12% | -6.63 | HTFL | /fcf-yield <GO> |
| Operating Margin | -6.10% | -36.40% | +30.30 | MMED | /operating-margins <GO> |
| Net Profit Margin | -10.70% | -60.00% | +49.30 | MMED | /net-margins <GO> |
| Revenue Growth (YoY) | 14.30% | 39.90% | -25.60 | HTFL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.82 | 26.00 | -21.18 | HTFL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.5 | 64.0 | -19.50 | HTFL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.90 | +0.15 | MMED | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.0x | 27.0x | -3.00 | MMED | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.14B | $5.13B | $8.5M | MMED | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMED REV | HTFL REV | MMED GROSS % | HTFL GROSS % | MMED FCF | HTFL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.10B | $176.0M | 54.2% | 76.8% | -$420.0M | -$59.0M |
| FY 2024 | $2.71B | $125.8M | 56.3% | 75.1% | -$53.0M | -$73.4M |
| FY 2023 | $2.47B | $87.2M | — | — | -$70.1M | -$80.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMED // BETA 1.05
HTFL // BETA 0.90